Study on Pharmacokinetics

Inclusion Criteria: 1. Signed Informed Consent Form * Signed written informed consent must be obtained from the subjects in accordance with requirements of the study center's IRB or IEC before the initiation of any protocol-required procedures. 2. Target Population * Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination findings, vital sign measurements, 12-lead ECG measurements, and clinical laboratory test results. 3. Age and Reproductive Status * Men and women of non-childbearing potential, ages 18 to 50 years, inclusive. Women must have documented proof that they are not of childbearing potential. Women must not be breastfeeding. * Males who are sexually active with women of childbearing potential (WOCBP) must agree to follow instructions for method(s) of contraception for the duration of treatment with study drug(s). Exclusion Criteria: * Women who are of childbearing potential or breastfeeding * Any significant acute or chronic medical illness * History of rhabdomyolysis or biliary disorders, including Gilbert's disease or Dubin-Johnson disease * Smokers (those who currently smoke, as well as those who have stopped smoking less than 6 months prior to the start of study drug administration) * Alcohol intake exceeding 2 standard drinks per days; however, no alcohol is allowed 1 week prior to the start of study drug administration and for the duration of the study * Any other sound medical, psychiatric, and/or social reason as determined by the investigator